Verve Therapeutics Inc (VERV)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Verve Therapeutics Revolutionizes Cardiovascular Care with $143.8 Million Public Offering
Verve Therapeutics Redefines Cardiovascular Medicine with Successful Pricing of Public Offering
Verve Therapeutics Inc: Pioneering Cardiovascular Therapies and Empowering Lives
The company published Revenue of $0.929 millions, in the financial interval ending September 30 2022
Verve Therapeutics Inc , decline in the operating conduct all over January to March 31 2022 period